Basic Information
Basic information for C5orf64-227-36aa
Peptide Name C5orf64-227-36aa
Genome Position chr5:61610631-61610715,61633848-61633870[+]
Species Human
Peptide Sequence MSTVWAPVRRALPFRHPAQLTSPRIDGEEFDYSVKT
Peptide Length 36
Unique No (C5orf64-215-36aa,C5orf64-216-36aa,C5orf64-218-36aa,C5orf64-219-36aa)
Grand Average of Hydropathicity -0.5139
Relative Molecular Mass 4790.33
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000671203;C5orf64-227
Transcript Length 2588
Coding Ability 0.5506
DNA Sequence Corresponding to Peptide ATGAGCACTGTCTGGGCTCCAGTTCGGCGGGCTTTGCCATTCAGGCATCCGGCGCAGCTGACAAGCCCGAGGATCGATGGAGAAGAGTTTGATTACTCAGTCAAAACC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :